{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:50:57Z","timestamp":1787068257436,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Long-time use of pharmacological immunosuppressive agents frequently leads to metabolic disorders. Most studies have focused on islet toxicity leading to posttransplantation diabetes mellitus. In contrast, the link between intestinal dysbiosis and immunosuppressive drug-induced metabolic disorders remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We established a mouse model of metabolic abnormality via sirolimus treatment. Fecal microbiota was examined using 16S rRNA gene MiSeq sequencing. Intestinal barrier function was assessed using fluorescein isothiocyanate-dextran assay and mucus immunostaining. Systemic inflammation was determined using a multiplexed fluorescent bead-based immunoassay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Sirolimus induced dyslipidemia and glucose intolerance in mice in a dose-dependent manner. Interestingly, the clinical-mimicking dose of sirolimus altered the intestinal microbiota community, which was characterized by the enrichment of Proteobacteria, depletion of\n                      <jats:italic toggle=\"yes\">Akkermansia<\/jats:italic>\n                      , and potential function shifts to those involved in lipid metabolism and the immune system. In addition, the clinical-mimicking dose of sirolimus reduced the thickness of the intestinal mucosal layer, increased the intestinal permeability, and enriched the circulating pro-inflammatory factors, including interleukin (IL)-12, IL-6, monocyte chemotactic protein 1, granulocyte-macrophage colony stimulating factor, and IL-1\u03b2. Our results showed a close association between intestinal dysbiosis, intestinal barrier failure, systemic inflammation, and metabolic disorders. Furthermore, we demonstrated that oral intervention in the gut microbiota by\n                      <jats:italic toggle=\"yes\">Lactobacillus rhamnosus<\/jats:italic>\n                      HN001 protected against intestinal dysbiosis, especially by depleting the lipopolysaccharide-producing Proteobacteria, and attenuated the sirolimus-induced systemic inflammation, dyslipidemia, and insulin resistance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Our study demonstrated a potentially causative role of intestinal dysbiosis in sirolimus-induced metabolic disorders, which will provide a novel therapeutic target for transplant recipients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000003494","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T12:01:37Z","timestamp":1603886497000},"page":"1017-1029","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Intestinal Dysbiosis Correlates With Sirolimus-induced Metabolic Disorders in Mice"],"prefix":"10.1097","volume":"105","author":[{"given":"Yuqiu","family":"Han","sequence":"first","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Throat Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Jia","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohong","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China."},{"name":"Research Units of Infectious Disease and Microecology, Chinese Academy of Medical Sciences, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects.","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease.","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.metabol.2014.02.004","article-title":"Short and long term in vivo effects of cyclosporine A and sirolimus on genes and proteins involved in lipid metabolism in Wistar rats.","volume":"63","author":"Lopes","year":"2014","journal-title":"Metabolism"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.transproceed.2011.05.001","article-title":"Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens.","volume":"43","author":"Gyurus","year":"2011","journal-title":"Transplant Proc"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1517\/14740338.2016.1132698","article-title":"Safety of mTOR inhibitors in adult solid organ transplantation.","volume":"15","author":"Ventura-Aguiar","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(03)12489-0","article-title":"Gut flora in health and disease.","volume":"361","author":"Guarner","year":"2003","journal-title":"Lancet"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2017.05.008","article-title":"Understanding the Holobiont: How microbial metabolites affect human health and shape the immune system.","volume":"26","author":"Postler","year":"2017","journal-title":"Cell Metab"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"9351507","DOI":"10.1155\/2017\/9351507","article-title":"Proteobacteria: A common factor in human diseases.","volume":"2017","author":"Rizzatti","year":"2017","journal-title":"Biomed Res Int"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance.","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaci.2013.06.022","article-title":"Innate sensors of pathogen and stress: linking inflammation to obesity.","volume":"132","author":"Jin","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.transproceed.2014.09.155","article-title":"Gastrointestinal disorders after renal transplantation.","volume":"46","author":"Savvidaki","year":"2014","journal-title":"Transplant Proc"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/acel.12380","article-title":"Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice.","volume":"14","author":"Hurez","year":"2015","journal-title":"Aging Cell"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/TP.0000000000001111","article-title":"The origin of new-onset diabetes after liver transplantation: Liver, islets, or gut?","volume":"100","author":"Ling","year":"2016","journal-title":"Transplantation"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11684-019-0686-8","article-title":"Antibiotics-mediated intestinal microbiome perturbation aggravates tacrolimus-induced glucose disorders in mice.","volume":"13","author":"Han","year":"2019","journal-title":"Front Med"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","article-title":"The pros, cons, and many unknowns of probiotics.","volume":"25","author":"Suez","year":"2019","journal-title":"Nat Med"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1039\/C8FO02163E","article-title":"Effects of probiotic supplementation on the regulation of blood lipid levels in overweight or obese subjects: a meta-analysis.","volume":"10","author":"Yan","year":"2019","journal-title":"Food Funct"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"e017995","DOI":"10.1136\/bmjopen-2017-017995","article-title":"Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials.","volume":"9","author":"Koutnikova","year":"2019","journal-title":"BMJ Open"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0007114500000210","article-title":"Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019).","volume":"83","author":"Gill","year":"2000","journal-title":"Br J Nutr"},{"issue":"2 Suppl","key":"R21-20250604","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/07315724.2001.10719027","article-title":"Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001.","volume":"20","author":"Sheih","year":"2001","journal-title":"J Am Coll Nutr"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"G1021","DOI":"10.1152\/ajpgi.00452.2013","article-title":"Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9.","volume":"306","author":"Good","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1017\/S0007114517000289","article-title":"Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial.","volume":"117","author":"Wickens","year":"2017","journal-title":"Br J Nutr"},{"key":"R24-20250604","first-page":"184","article-title":"Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function.","volume":"309","author":"Anderson","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3748\/wjg.v23.i15.2696","article-title":"Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study.","volume":"23","author":"Toscano","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature14232","article-title":"Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.","volume":"519","author":"Chassaing","year":"2015","journal-title":"Nature"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"38783","DOI":"10.1038\/srep38783","article-title":"Effect of unplanned therapy on the prognosis of patients with extremity osteosarcoma.","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data.","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat Methods"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences.","volume":"31","author":"Langille","year":"2013","journal-title":"Nat Biotechnol"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/bioinformatics\/btq041","article-title":"Identifying biologically relevant differences between metagenomic communities.","volume":"26","author":"Parks","year":"2010","journal-title":"Bioinformatics"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.imbio.2016.09.014","article-title":"mTORC1 inhibition with rapamycin exacerbates adipose tissue inflammation in obese mice and dissociates macrophage phenotype from function.","volume":"222","author":"Paschoal","year":"2017","journal-title":"Immunobiology"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/db09-1324","article-title":"Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.","volume":"59","author":"Houde","year":"2010","journal-title":"Diabetes"},{"key":"R34-20250604","first-page":"697","article-title":"Gut microbial community structure and complications after kidney transplantation: a pilot study.","volume":"98","author":"Lee","year":"2014","journal-title":"Transplantation"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes.","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.gastro.2020.03.010","article-title":"Lactococcus lactis Subspecies cremoris elicits protection against metabolic changes induced by a western-style diet.","volume":"159","author":"Naudin","year":"2020","journal-title":"Gastroenterology"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-20250604","first-page":"1","article-title":"A next generation probiotic, Akkermansia muciniphila.","volume":";59","author":"Zhai","year":"2018","journal-title":"Critical reviews in food science and nutrition"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1038\/s41598-017-10471-2","article-title":"Impact of immunosuppression on the metagenomic composition of the intestinal microbiome: a systems biology approach to post-transplant diabetes.","volume":"7","author":"Bhat","year":"2017","journal-title":"Sci Rep"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1172\/JCI105976","article-title":"Effects of dietary fats on plasma lipids and lipoproteins: an hypothesis for the lipid-lowering effect of unsaturated fatty acids.","volume":"48","author":"Spritz","year":"1969","journal-title":"J Clin Invest"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"101020","DOI":"10.1016\/j.plipres.2019.101020","article-title":"A global perspective on the crosstalk between saturated fatty acids and Toll-like receptor 4 in the etiology of inflammation and insulin resistance.","volume":"77","author":"Li","year":"2020","journal-title":"Prog Lipid Res"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises.","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation.","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/jpn.12375","article-title":"Rapamycin, a specific inhibitor of the target of rapamycin complex 1, disrupts intestinal barrier integrity in broiler chicks.","volume":"100","author":"Liu","year":"2016","journal-title":"J Anim Physiol Anim Nutr (Berl)"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1432-2277.2010.01167.x","article-title":"Systemic influence of immunosuppressive drugs on small and large bowel transport and barrier function.","volume":"24","author":"Malinowski","year":"2011","journal-title":"Transpl Int"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.it.2014.12.008","article-title":"Versatile functions for IL-6 in metabolism and cancer.","volume":"36","author":"Mauer","year":"2015","journal-title":"Trends Immunol"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes.","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/AEM.66.6.2578-2588.2000","article-title":"Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20.","volume":"66","author":"Tannock","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:07:52Z","timestamp":1749049672000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003494","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}